Chinese Journal of Hepatology 2007 Issue 6 Construction of eukaryotic expression vectors containing different haplotype cDNA of human CⅡTA gene

Construction of eukaryotic expression vectors containing different haplotype cDNA of human CⅡTA gene
BAI Xiu-Juan;ZHANG Xu-qing;HONG Xiao-jun

..............page:445-449

An experimental study on the reverse mechanism of PPAR- γ agonist rosiglitazone in rats with nonalcoholic steatohepatitis
ZHAO Cai-yan;WANG Ya-dong;ZHOU Jun-ying;JIA Bei;CUI Jun-feng

..............page:450-455

Direct more emphasis on different etiologies of end-stage liver disease during treatment
LIU Ke-zhou

..............page:456-457

Treatment of commonly seen complications in end-stage liver disease
DUAN Zhong-ping;CHEN Yu

..............page:458-460

A clinical analysis of digestive tract fungus infection in patients with liver cirrhosis
DAI Min

..............page:460-461

Adjustment of blood coagulation during the perioperation period of emergency liver transplantation
MU Zhen-guo;CAO Guang-tao;GUO Jian-guang;XU Gui-xing;ZHANG Peng-fei;HAN Li;YIN Ge;HAO Jin-cheng;SHANG Xi;CAO Jun;LIU Jun

..............page:462-463

Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis
LIN Qu;HUANG Ming-sheng;HU Bo;DONG Min;WEN Jing-yun;WU Xiang-yuan

..............page:463-464

The antigenicities of 15 expressed hepatitis B surface antigen variants
TIAN Yong-jun;ZHANG Zhen-hua;QIN Li;LIU Shen-pei;GONG Jin-song;ZHANG Zheng-mao;LU Meng-ji;YANG Dong-liang

..............page:465-466

A comparison of therapeutic outcomes in liver fibrosis of murine schistosomiasis japonica with interferon-alpha and interferon-gamma
WANG Wei-ya;LI Fei;JIA Xue-mei;WANG Hong;LI Cui-ying;JIN Liang

..............page:467-468

Genetic instability of nm23H1 gene and invasion and/or metastasis of hepatocellular carcinoma
ZHONG Jian-ping;LU Hai-ying;LI Ji-cheng

..............page:469-470

Effect of blocking Wnt/β -catenin signaling pathway on apoptosis of activated hepatic stellate cells
WENG Zhi-hong;LEI Yan-chang;PENG Cheng;ZHANG Shu-ling

..............page:471-472

Effects of human bone marrow mesenchymal stem cell transplantation into rats with liver regeneration failure
TAN Hao-xiang;GAO Yi;CHEN Jiang-feng

..............page:473-474

Recombinant adenovirus vector with Fas (CD95)-targeted shRNAs inhibited LPS-inducing Fas overexpression of mouse hepatocytes
LIU Ming-she;ZHAO Zhong-fu;WANG Lan;ZHANG Guo-ying;ZHANG Yun;YANG Hui;QIAO Jing-gui;HAN De-wu

..............page:475-476

xiao xi

..............page:416,440

du zhe zuo zhe bian zhe

..............page:411,421,436,449,455

AASLD practice guidelines: chronic hepatitis B
LUO Sheng-qiang;ZHANG Ling-xia

..............page:477-480

Molecular mechanisms of DHEA and DHEAs on apoptosis and cell cycle arrest via Akt pathway in hepatoma cell lines
JIANG Yan-fang;ZHAO Ping-wei;TAN Yan;LIU Li-hua;LI Ming-hui;Yasushi Matsuzaki;NIU Jun-qi

..............page:441-444

Separation and identification of the exosomes derived from a mouse hepatoma carcinoma cell line (H22) and initial investigation of their protein composition
LI Jing;SHEN Yi;TANG Wei-xue;CHEN Li;DUAN Hong

..............page:437-440

An economic evaluation of different treatments for HBeAg-positive chronic hepatitis B in China
Larry Lacey;LU Xian-zhong;Alison Tan

..............page:431-436

An analysis of clinical features in HBeAg-negative and HBeAg-positive chronic hepatitis B
OU Xiao-juan;WANG Xiao-ming;WANG Bao-en;WANG Tai-ling;MA Hong;YOU Hong;JIA Ji-dong

..............page:428-430

The relationship between HBV genotypes and the efficacy of antiviral therapies in hepatitis B e antigen-positive patients
ZOU Huai-bin;ZHU Li-min;ZHAO Gui-ming;LIANG Shu-ren;LI Jia;LU Cheng-zhen;LI Hai

..............page:425-427

Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha
LIU Ding-li;LUO Kang-xian;FENG Xiao-rong;ZHANG Ming-xia;HOU Jin-lin

..............page:422-424

Establishing a L02 cell model with whole HBV gene transfection and analyzing its expressions of HLA-A, B, C and MICA/B
CHEN Min;PENG Ming-li;SHI Qing-feng;REN Hong

..............page:417-421

Assessment of the health-related quality of life of patients with minimal hepatic encephalopathy
BAO Zhi-jun;QIU De-kai;MA Xiong;ZHANG Gan-sheng;FAN Zhu-ping;HUANG Yi-qin;YU Xiao-feng;ZENG Min-de

..............page:412-416

An evaluation of the prognosis of patients with chronic severe hepatitis using a model for end-stage liver disease
CAI Chang-jie;LU Min-qiang;CHONG Yu-tian;CHEN Huan;CHEN Gui-hua

..............page:408-411

Renal type Ⅰ inositol 1,4,5-triphosphate receptors expression increases in fulminant hepatic failure in mice
WEN Ying;CUI Wei;LIU Pei

..............page:403-407

Diagnosis and treatment of end-stage liver disease
JIA Ji-dong

..............page:401-402